Cline Christopher R.insider trades
In SEC Form 4 filings, Cline Christopher R. is listed as CHIEF FINANCIAL OFFICER of Travere Therapeutics, Inc. (TVTX). In the last 90 days, Cline Christopher R. sold $3.19M of Travere Therapeutics, Inc. (TVTX) on the open market and bought none. 4 of the 5 sales were reported under a 10b5-1 trading plan.
Companies and roles
| Company | Role | Transactions | Last filed |
|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | CHIEF FINANCIAL OFFICER | 7 | Sep 17 |
Cluster buys
No cluster buy in the last 90 days included a purchase by this insider (two or more insiders buying within 14 days).
Form 4 historysince 2026-09-03
| Company | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M | 20,000 | $17.44 | $348,800 | 138,016 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 27,473 | $62.00 | Sale −$1,703,241 | 110,543 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 20,735 | $62.61 | Sale −$1,298,175 | 89,808 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 1,900 | $63.69 | Sale −$121,004 | 87,908 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | S | 400 | $65.31 | Sale −$26,124 | 87,508 | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 15 | Sep 17 | M · derivative | 20,000 | $17.44 | $348,800 | not reported | Yes | Form 4 |
| TVTXTravere Therapeutics, Inc. | Sep 2 | Sep 3 | S | 642 | $66.37 | Sale −$42,610 | 118,016 | No | Form 4 |
Published from this insider's public Form 4 filings on SEC EDGAR; the name is shown as filed. Named in a filing and want this page removed? See the privacy policy.